
Daily intake of aspirin for over 60s no longer advised
(MENAFN- Newsroom Panama) The daily intake of aspirin to reduce the risk of heart attack or stroke should no longer be recommended in the United States for people aged 60 and over, a panel of experts warned on Tuesday, October 12.
"Daily use of aspirin can help prevent heart attacks and strokes in some, but it can also cause serious adverse effects, such as internal bleeding," said Dr. John Wong, a member of the Preventive Services Task Force of the United States, in a statement.
As for people aged 40 to 59, at-risk but without a history of cardiovascular disease, they must individually make the decision to start this treatment, after consulting their doctor, these experts add.
It is a radical change that affects millions of people because its practice is widespread in the country. Cardiovascular disease is the leading cause of death in the United States.
Since 2016, Task Force experts, whose recommendations are widely followed, have recommended aspirin for people in their 50s with an assessed risk of 10% of heart attack or stroke in the next ten years.
They also believed that 60-year-olds at risk could take this preventive treatment based on an individual decision.
But for several years, studies have questioned the American recommendations.
Aspirin thins the blood, which prevents clots and helps reduce the risk of heart attack or stroke.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Versus Trade Launches Master IB Program: Multi-Tier Commission Structure
- Mutuum Finance (MUTM) New Crypto Coin Eyes Next Price Increase As Phase 6 Reaches 50% Sold
- Flexm Recognized As“Highly Commended” In The Regtech Category At The Asia Fintech Awards Singapore 2025
- Tappalpha's Flagship ETF, TSPY, Surpasses $100 Million In AUM
- Stocktwits Launches Stocktoberfest With Graniteshares As Title Partner
- Pendle Grows An Additional $318 Million TVL Just 4 Days After Plasma Launch
Comments
No comment